News Headlines

• X Chromosome Dosage Compensation Does Occur In Germ Cells
  ...X chromosome dosage compensation does occur in germ cells. A study published today in the open access journal Journal of Biology reveals that expression of the genes on the X chromosome is doubled in Drosophila germ cells to compensate for the missing second X chromosome. The study shows that this also occurs in C... click link for more info....
  MedicalNewsToday - Sat, 18 Feb 2006 11:00 EST
  
• X Chromosomes Key To Sex Differences In Health
  ...Females have two X chromosomes and males only have one -- and this simple fact, along with the occurrence of what geneticists call mosaicism, may not only explain why women are less susceptible than men to certain genetic diseases, but also may account for the female prevalence in the incidence of other conditions and even sex differences in behavior, according to a special communication in the March 22/29 issue of JAMA, a theme issue on women''s health....
  ScienceDaily - Thu, 23 Mar 2006 03:00 EST
  
• X Chromosomes Key To Sex Differences In Health
  ...Females have two X chromosomes and males only have one - and this simple fact, along with the occurrence of what geneticists call mosaicism, may not only explain why women are less susceptible than men to certain genetic diseases, but also may account for the female prevalence in the incidence of other conditions and even sex differences in behavior, according to a special communication in the March 22/29 issue of JAMA, a theme issue on women''s health... click link for more info....
  MedicalNewsToday - Fri, 24 Mar 2006 07:00 EST
  
• X Rays Reveal Cell's Fight Against Cancer As Struggle Between Pro- And Anti-tumor Proteins
  ...Molecular biologists document the first step in one type of tumor: a virus homes in on a cell's most important defender, inhibiting its anti-cancer properties....
  ScienceDaily - Wed, 06 Sep 2006 03:00 EST
  
• X-rays raise breast cancer risk in some women: study
  ... WASHINGTON (Reuters) - X-rays may greatly raise the risk of breast cancer in women who are genetically susceptible to the disease, researchers reported on Monday....
  Reuters - Mon, 26 Jun 2006 10:24 EST
  
• X-Rays Studied for Breast Cancer Risk
  ...Chest X-rays may up breast cancer risk in women with the breast cancer gene mutations BRCA1 or BRCA2, a new study shows....
  WebMD - Wed, 28 Jun 2006 06:52 EST
  
• X-SCID Gene Therapy Poses Substantial Cancer Risk
  ...New animal studies conducted at the Salk Institute for Biological Studies show that the only human gene therapy treatment to date considered to be largely successful, is, in fact, riskier than realized.The Salk researchers, led by Inder Verma, Ph.D., a professor in the Laboratory of Genetics, discovered that the healthy copy, which replaces the defective gene can itself promote cancer development... click link for more info....
  MedicalNewsToday - Sun, 30 Apr 2006 11:00 EST
  
• Xaliproden Reduces Occurrence Of Severe Peripheral Sensory Neuropathy Associated With Oxaliplatin-based Regimen, Study
  ...Sanofi-aventis announced today that the final results of the Xenox trial showed that the experimental non-peptide compound xaliproden reduced the risk of occurrence of grade 3 peripheral sensory neuropathy (PSN) by 39% in patients treated with oxaliplatin injection-based therapy, without impacting the response rate of the oxaliplatin regimen... click link for more info....
  MedicalNewsToday - Fri, 24 Feb 2006 05:00 EST
  
• XanGo juice drink maker gets FDA warning
  ...WASHINGTON (Reuters) - The U.S. Food and Drug Administration has warned the maker of tropical fruit drink XanGo over claims the beverage can prevent or treat cancer, depression, infection, Alzheimer's disease and other ailments....
  Reuters - Tue, 03 Oct 2006 07:05 EST
  
• Xango juice drink not a cure-all, FDA warns
  ...WASHINGTON (Reuters) - Xango, a tropical fruit beverage, is not proven to treat or prevent any diseases, despite its manufacturer's claims, U.S. health regulators warned after a review of promotional materials....
  Reuters - Tue, 03 Oct 2006 03:38 EST
  
• Xanthus' Symadex Can Reverse Disease In Preclinical Multiple Sclerosis Animal Model
  ...Xanthus Pharmaceuticals, Inc., a privately-held drug development company, today presented data that Symadex(TM) reverses the clinical and pathological signs of chronic disease in an animal model for multiple sclerosis (MS). The presentation was made by Stephen J. [click link for full article]...
  MedicalNewsToday - Fri, 29 Sep 2006 07:00 EST
  
• XCPT(TM) Treatment Planning And Communication Software For Dentists To Be Used By University Of Pennsylvania School Of Dental Medicine
  ...XCPT, LLC has signed an agreement with the University of Pennsylvania to place XCPT's Treatment Planning and Communication Software solution at the Penn School of Dental Medicine. XCPT's software is a highly graphic, face-to-face, patient consultation and treatment planning method that recognizes the importance of visual learning during treatment planning. [click link for full article]...
  MedicalNewsToday - Sat, 24 Feb 2007 08:00 EST
  
• XCPT(TM) Treatment Planning And Communication Software For Dentists To Be Used By University Of Pennsylvania School Of Dental Medicine
  ...XCPT, LLC has signed an agreement with the University of Pennsylvania to place XCPT's Treatment Planning and Communication Software solution at the Penn School of Dental Medicine. XCPT's software is a highly graphic, face-to-face, patient consultation and treatment planning method that recognizes the importance of visual learning during treatment planning. [click link for full article]...
  MedicalNewsToday - Sat, 24 Feb 2007 08:00 EST
  
• Xeloda Should Replace Burdensome Intravenous Chemotherapy
  ...Data presented this weekfurther strengthens the wealth of evidence showing that Xeloda(R)(capecitabine), an innovative oral chemotherapy, should replace the currentstandard treatment of intravenous 5-fluorouracil/leucovorin (i... click link for more info....
  MedicalNewsToday - Wed, 18 May 2005 08:00 EST
  
• Xeloda wins EU approval for adjuvant therapy in colon cancer treatment
  ...Colon cancer patients have access to a new, more convenient and safer treatment option compared to the current standard of therapy - Roche announced today that the European authorities have approved Xeloda (capecitabine), an innovative oral chemotherapy, to be used as an adjuvant treatment (post-surgery) for colon cancer... click link for more info....
  MedicalNewsToday - Fri, 01 Apr 2005 09:04 EST
  
• Xeloda(R) Combination Meets Primary Endpoint In International Phase III Advanced Colorectal Cancer Study
  ...Roche announced today that a large, international Phase III study (NO16967) of 627 previously treated patients with advanced colorectal cancer met its primary endpoint of progression-free survival. [click link for full article]...
  MedicalNewsToday - Sun, 24 Dec 2006 08:00 EST
  
• Xeloda(R) Plus Avastin(R) Combination May Produce Clinical Benefit In Patients With Advanced Breast Cancer
  ...An interim analysis of the XCALIBr (Xeloda in Combination with Avastin as First-Line Treatment for HER2-Negative Metastatic Breast Cancer) trial suggested that first-line therapy with oral Xeloda(R) (capecitabine) in combination with Avastin(R) (bevacizumab) may offer clinical benefit in metastatic breast cancer patients who have no prior history of treatment. [click link for full article]...
  MedicalNewsToday - Sat, 16 Dec 2006 08:00 EST
  
• XELOX (Xeloda(R) + Oxaliplatin) Shown To Be As Effective As Current Standard In The Treatment Of Advanced Colorectal Cancer
  ...Roche announced that the latest results from an international, Phase III study showed the chemotherapy combination XELOX (Xeloda + oxaliplatin) to be as effective -- in terms of progression-free survival (PFS) -- as the current standard treatment, FOLFOX-4 (infused 5-FU/leucovorin + oxaliplatin), in the treatment of advanced (metastatic) colorectal cancer. [click link for full article]...
  MedicalNewsToday - Tue, 03 Oct 2006 07:00 EST
  
• Xenical helps obese teens shed weight
  ... NEW YORK (Reuters Health) - When combined with a low-calorie diet, exercise and behavioral therapy, treatment with Xenical significantly improves weight management for obese teenagers, new research suggests....
  Reuters - Wed, 15 Jun 2005 08:25 EST
  
• Xenical Helps Teens Trim Pounds
  ...Title: Xenical Helps Teens Trim PoundsCategory: Health NewsCreated: 6/15/2005 1:57:00 AMLast Editorial Review: 6/15/2005 1:57:14 AM...
  MedicineNet - Wed, 15 Jun 2005 06:00 EST
  
• Xenon Gas Safe In Surgery And Could Help Stop Nerve Damaging Illnesses
  ...Scientists have successfully conducted the first clinical trial giving xenon gas to patients undergoing coronary artery bypass grafting in order to safeguard against postoperative brain damage that can occur following this procedure. Research published in Anesthesiology shows how the team safely gave xenon to 12 patients undergoing coronary artery bypass grafting while on cardiopulmonary artery bypass, a step which could eventually lead to new treatments for people suffering from illnesses that damage nerve cells, such as strokes, and brain and spinal cord injuries... click link for more info....
  MedicalNewsToday - Sat, 25 Feb 2006 03:00 EST
  
• Xenon Gas Safe In Surgery And Could Help Stop Nerve Damaging Illnesses, New Study Shows
  ...Scientists have successfully conducted the first clinical trial giving xenon gas to patients undergoing coronary artery bypass grafting in order to safeguard against postoperative brain damage that can occur following this procedure.Research published in Anesthesiology shows how the team safely gave xenon to 12 patients undergoing coronary artery bypass grafting while on cardiopulmonary artery bypass, a step which could eventually lead to new treatments for people suffering from illnesses that damage nerve cells, such as strokes, and brain and spinal cord injuries... click link for more info....
  MedicalNewsToday - Mon, 27 Feb 2006 11:00 EST
  
• XenoPort Announces Presentation Of XP13512 Data At The American Pain Society Meeting
  ...XenoPort, Inc.(Nasdaq: XNPT) announced today that additional data from the company'sPhase 2a clinical trial of XP13512 for the treatment of post-herpeticneuralgia, or PHN, will be presented by Miroslav Backonja, M.D., at theAmerican Pain Society Annual Meeting, May 3-6, 2006 in San Antonio, Texas... click link for more info....
  MedicalNewsToday - Fri, 05 May 2006 06:00 EST
  
• Xfam Criticizes G8 Nations For Failing To Sufficiently Increase Aid For Development Programs, Including HIV/AIDS Initiatives
  ...Oxfam on Friday released a report criticizing the Group of Eight industrialized nations for not providing enough aid to international development programs -- including programs to fight HIV/AIDS -- and for pulling money from aid budgets to cancel debt owed by developing countries, the AP/Yahoo! News reports. The report, released Friday ahead of this year's G8 summit in St. [click link for full article]...
  MedicalNewsToday - Thu, 15 Jun 2006 10:00 EST
  
• Xie Lab Demonstrates The Role Of MicroRNA Pathway
  ...Ting Xie, Ph.D., Associate Investigator, and Zhigang Jin, Ph.D., Postdoctoral Research Associate in the Xie Lab, have published results showing that the microRNA pathway is essential for controlling self-renewal of germline stem cells and somatic stem cells in the Drosophila ovary.The paper, "Dcr-1 Maintains Drosophila Ovarian Stem Cells," is published on the Web site of Current Biology. [click link for full article]...
  MedicalNewsToday - Sun, 18 Feb 2007 07:00 EST
  
• XL Americans too fat for X-rays, study finds
  ...More and more obese people are unable to get full medical care because they are either too big to fit into scanners, or their fat is too dense for X-rays or sound waves to penetrate, radiologists reported Tuesday....
  MSNBC - Tue, 25 Jul 2006 08:39 EST
  
• XLHealth Invites Over 5,000 Additional Medicare Beneficiaries To Participate In Tennessee's Medicare Health Support Program
  ...XLHealth, one of the nation's leading disease management companies, is inviting approximately 5,600 additional Medicare beneficiaries to participate in Tennessee's Medicare Health Support pilot program. [click link for full article]...
  MedicalNewsToday - Tue, 16 Jan 2007 08:00 EST
  
• Xolair ''add-on'' helpful in uncontrolled dermatitis
  ... NEW YORK (Reuters Health) - Individuals with severe persistent dermatitis who fail to gain adequate control despite standard treatments may find relief with the addition of Xolair (omalizumab), according to a group of dermatologists from Georgia....
  Reuters - Fri, 13 Jan 2006 04:18 EST
  
• Xolegel Treats Seborrheic Dermatitis
  ...Title: Xolegel Treats Seborrheic DermatitisCategory: Health NewsCreated: 8/1/2006 1:57:00 AMLast Editorial Review: 8/1/2006 1:56:54 AM...
  MedicineNet - Tue, 01 Aug 2006 06:00 EST
  
• XVI International AIDS Conference Announces Program, Including Prominent Leaders And Scientists
  ...The XVI International AIDS Conference, to be held Aug. 13 to Aug. 18 in Toronto, will feature a number of prominent speakers, including former U.S. President Clinton, former President of Ireland Mary Robinson, Crown Princess Mette-Marti of Norway, Bill and Melinda Gates and actor Richard Gere, VOA News reports (De Capua, VOA News, 6/29). [click link for full article]...
  MedicalNewsToday - Tue, 04 Jul 2006 01:00 EST